Yaxiong Zhang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0009-0001-9880-3834

发表论文 43 篇 · 总被引 230 次 · h-index 7

代表论文

Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes (2024 · Journal of the National Cancer Center · 被引 5)
Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study (2024 · Frontiers in Immunology · 被引 5)
EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ (2026 · Journal of Clinical Investigation · 被引 3)
The evolving landscape of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: inspiration from cisplatin-based antiemetic and non-antiemetic trials (2024 · Supportive Care in Cancer · 被引 2)
First case report of immune checkpoint inhibitor-related pneumonitis triggered by bispecific antibody (anti-PD-L1 and anti-CTLA-4) in a patient with non-small cell lung cancer: case report (2025 · Translational Lung Cancer Research · 被引 1)
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors (2025 · MedComm)